QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

AGMB

QT66AgomAb Therapeutics N.V. American Depositary Shares
NASDAQ·Healthcare·Biotechnology·BE
Latest market price
10.98
+0.88+8.71%
OverviewShort InterestFilings
AGMBQT66AgomAb Therapeutics N.V. American Depositary Shares·NASDAQ
OverviewShort InterestFilings
10.98+8.71%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-
Insider Own-
Shs Outstand49.25M
Perf Week11.13%
Market Cap497.69MForward P/E-EPS next Y-Insider Trans-Shs Float-Perf Month4.47%
Enterprise Value497.69MPEG-EPS next Q-Inst Own-Short Float-Perf Quarter-13.54%
Income-72115241.00P/S0.00EPS this Y-Inst Trans-Short Ratio-Perf Half Y-
Sales-P/B0.00EPS next Y-ROA0.00%Short Interest-Perf YTD-
Book/sh3.96P/C0.00EPS next 5Y-ROE0.00%52W High-Perf Year-
Cash/sh3.61P/FCF0.00EPS past 3/5Y-ROIC0.00%52W Low-Perf 3Y-
Dividend Est.-EV/EBITDA-9.46Sales past 3/5Y-Gross Margin0.00%Volatility5.73% 6.53%Perf 5Y-
Dividend TTM-EV/Sales0.00EPS Y/Y TTM-Oper. Margin0.00%ATR (14)1.01Perf 10Y-
Dividend Ex-Date-Quick Ratio0.00Sales Y/Y TTM-Profit Margin0.00%RSI (14)52.13Recom-
Dividend Gr. 3/5Y-Current Ratio0.00EPS Q/Q-SMA201.66%Beta1.70Target Price-
Payout0.00%Debt/Eq0.00Sales Q/Q-SMA500.03%Rel Volume1.60Prev Close10.10
Employees57LT Debt/Eq0.01Earnings-SMA200-Avg Volume118.14KPrice10.98
IPO DateMay 29, 2024Option/ShortYes / YesEPS/Sales Surpr.-Net Debt/EBITDA0.00Volume188,958Change8.71%
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
Total Revenue
000
Cost of Goods Sold Incl. D&A
000
Gross Profit
000
Selling, General and Administrative Excl. Other1165
Research and Development432820
Other Operating Expense-20-1
Operating Income-52-34-24
Interest Expense
000
Unusual Expense
———
Non-Operating Income (Expense)-2-21-12
Net Income Before Taxes-50-13-11
Income Taxes0-1-3
Consolidated Net Income-50-12-9
Net Income From Continuing Operations-50-12-9
Net Income-50-12-9
EPS (Recurring)-1.36-0.34-0.23
EPS (Basic, Before Extraordinaries)-1.36-0.34-0.23
EPS (Diluted)-1.36-0.34-0.23
EBITDA-50-13-11
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio
———
Gross Margin
———
Operating Margin
———
Net Margin
———
Shares Outstanding363636
Market Capitalization
———
Operating Lease Expense
———
Insider Trading Volume
$11.94$10.75$9.56$8.37$7.18● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR